News analysis for professionals in the cannabis industry

Covid helps fuel cannabis acquisitions by Greenlane and Dutchie

Written by Lorraine Mullaney | 11th May 2021

Two US firms, Greenlane and KushCo, have merged in a deal that aims to create a major manufacturer and distributor of cannabis accessories in the US ...

Cannabis lobbying steps up in the US with major players joining the discussion

Written by CannIntelligence | 10th May 2021

Significant cannabis reform is inevitably coming to congress, no matter whether the Biden administration considers it a priority, and giants in experienced lobbying industries are preparing their agents ...

Growing medical market prompts expansion in New York and Pennsylvania

Written by Lorraine Mullaney | 7th May 2021

When Biden won the US election in November 2020 the stock market value of cannabis firms soared in expectation of a more lenient political climate under the Biden administration ...

Heading south: Valens and Canopy increase presence in US CBD market

Written by Lorraine Mullaney | 6th May 2021

Various business deals across the US and Canada see cannabis and CBD companies expanding their portfolios and growing their brands in a series of acquisitions, investments and partnerships ...

Legalisation of cannabis looks like being a hot topic in Germany's federal elections

Written by CannIntelligence | 3rd May 2021

With federal elections due in September, Germany’s Free Democratic Party (FDP) has called on the government to draft a law permitting the controlled distribution of cannabis for adult use ...

South Africa's new national cannabis plan could spark regional change

Written by CannIntelligence | 30th April 2021

South Africa releases the National Cannabis Master Plan, which will not only boost and uplift the southern Africa cannabis industry, but will set a regional precedent for the growth of a legal cannabis market in the area ...

Opposition parties put forward proposals for legalisation of cannabis in Poland

Written by CannIntelligence | 29th April 2021

Poland’s Parliamentary Team for the Legalisation of Marijuana has submitted a package of three draft bills to the speaker of parliament’s lower chamber, following a public consultation on the proposals ...

Minor cannabinoids: what are they, and how could they be of benefit?

Written by CannIntelligence | 28th April 2021

CBD-Intel offers a review of the science behind some of cannabis’s lesser-known compounds – the so-called “minor cannabinoids” – with an emphasis on their potential applications ...

UK FSA releases initial validated novel food application list

Written by Freddie Dawson | 23rd April 2021

The long-anticipated UK Food Standards Agency (FSA) initial list of products supported by a validated CBD novel food application has been released ...

CBD and Covid-19 – lab experiments show promise, but don't hold your breath

Written by CannIntelligence | 21st April 2021

Early research into the possibility of CBD having a role to play in the fight against coronavirus infections has shown some initial promise. Any practical application remains a long way off, however ...

Cann Group teams up with Emyria to develop pharmacy grade CBD capsules

Written by Lorraine Mullaney | 21st April 2021

Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria ...

Jersey well placed to become Europe’s major growing hub for medical cannabis

Written by Lorraine Mullaney | 20th April 2021

Jersey could become “a cannabis hub for Europe” after Northern Leaf successfully completed a second round of funding that will enable it to complete its pharmaceutical cannabis cultivation facility on the island ...

A new head honcho for CBD policy – but who will US FDA pick for this vital role?

Written by CannIntelligence | 19th April 2021

A new deputy commissioner at the US Food and Drug Administration (FDA) will likely be the single person with the most influence on the path to market for CBD in the US ...

The next big thing – or are investors in psychedelics playing the long game?

Written by CannIntelligence | 19th April 2021

While legal cannabis is still a relatively new industry, investors are already looking for the next sector to boom – and many think that will be psychedelics ...

Credit union runs into trouble with US agency over too-lax cannabis activities

Written by CannIntelligence | 16th April 2021

Access to banking services has been a problem for the legal cannabis sector in the US from the beginning – and the experience of one cooperative in Michigan shows that the relationship can be problematic...

US Customs stands accused of seizing legal hemp – and farm machinery

Written by Anthony Traurig | 16th April 2021

The US Customs and Border Protection (CBP) agency is wrongly seizing legal hemp and hemp-related shipments – such as farm equipment that it claims constitutes drug paraphernalia – according to two recently-filed lawsuits ...

New Senate request could hold Mexican legalisation back until at least September

Written by CannIntelligence | 15th April 2021

Mexico’s Senate is poised to request extra time to approve legislation that would legalise cannabis in the country, prolonging debate over the highly anticipated bill until September ...

Tilray expands its influence Down Under, moving on New Zealand medical market

Written by Lorraine Mullaney | 15th April 2021

Canadian cannabis firm Tilray is moving in on New Zealand’s market for medical cannabis and has received the necessary approvals to launch Tilray medical cannabis products across the country ...

Details of China's proposed ban on CBD in cosmetics still unclear

Written by CannIntelligence | 14th April 2021

Suggestions that a Chinese ban on the use of CBD in cosmetics that would essentially shut down the domestic CBD market, blocking imports and cross-border online sales, appear to be premature ...

'A nice buzz in the air' – CBD shops reopen as UK lockdown lifts

Written by CannIntelligence | 14th April 2021

As the national lockdown in the UK lifted on Monday, shoppers were excited to purchase CBD in person ...

‘Cautious’ Idaho is ready at last to become the 50th state to legalise industrial hemp

Written by CannIntelligence | 13th April 2021

It’s been a long process getting there, but the last US state to legalise industrial hemp finally has a bill headed to the governor’s desk and farmers poised to plant the crop ...

How cannabis derivatives could help to preserve the miracle of modern medicine

Written by CannIntelligence | 13th April 2021

Could cannabinoids, including CBD, provide a partial solution to the growing danger of diseases becoming resistant to existing antibiotics? ...

Could cannabinoids help in the fight against drug-resistant bacteria?

Written by CannIntelligence | 12th April 2021

Scientific findings on the antimicrobial properties of cannabis – and in particular cannabinoids – have raised the question of whether they might play a role in combatting antibiotic-resistant bacteria such as MRSA ...

A mixed bag: reactions to the USDA's final hemp rule requirements

Written by CannIntelligence | 9th April 2021

States continue to update their hemp production plans to match US Department of Agriculture (USDA) final rule requirements, with Michigan being one of the latest ...

Italy issues its first licences to grow hemp and extract CBD for medical use

Written by CannIntelligence | 8th April 2021

Italy’s Ministry of Health and the Italian Medicine Agency (AIFA) have begun authorising Italian companies to manufacture hemp-derived CBD extracts for pharmaceutical purposes ...

Delta-8 THC – hot new kid on the block, or hemp's disturbing problem child?

Written by CannIntelligence | 7th April 2021

The newest cannabinoid craze is stirring up controversy in the emerging legal hemp industry. Delta-8 THC, produced from hemp-extracted CBD, promises a legal high – but, many wonder, at what cost? ...

Germany’s highest court leaves legality of hemp flowers open to interpretation

Written by CannIntelligence | 6th April 2021

Germany’s highest civil and criminal court has ruled that low-THC industrial hemp flowers may be considered a narcotic – but that they can be legally sold to German consumers if there is no risk of...

CBD firms find more pros than cons in legal recreational cannabis markets

Written by CannIntelligence | 6th April 2021

CBD companies see more synergies than threats from the provision of legal cannabis products in states such as Colorado, which has one of the oldest recreational cannabis markets in the US ...

US and Australian cannabis companies see great profit potential in Europe

Written by Lorraine Mullaney | 2nd April 2021

There are profits to be made from selling cannabis in Europe, according to US company Curaleaf after it signed an agreement to acquire Europe’s largest vertically integrated independent cannabis company ...

Rethink needed after belated discovery that bats student confused CBD with THC

Written by CannIntelligence | 1st April 2021

A lab technician’s slip-up five decades ago could cause a complete rethink of cannabis and CBD regulation in many jurisdictions, legal scholars warned today ...

'Impending disaster' – UK industry associations at odds over THC limits

Written by CannIntelligence | 31st March 2021

The British Hemp Alliance (BHA) has contested the suggestion put forward by the Association for the Cannabinoid Industry (ACI) for allowable THC levels in CBD products, claiming it would only benefit “the big boys” ...

US FDA: You can't hide health claims for CBD behind other active ingredients

Written by Freddie Dawson | 31st March 2021

The US Food and Drug Administration (FDA) has assessed a combined health claim for the first time and denounced the practice of promoting CBD on a product making qualified health claims based on other...

Could Oregon state bill show a way out of US cannabis and CBD banking troubles?

Written by CannIntelligence | 30th March 2021

An Oregon senator believes he has found a solution to the cannabis banking crisis in the state, and perhaps set a useful standard for others across the US ...

US FDA warns CBD firms over inadequate testing, labelling and health claims

Written by Freddie Dawson | 29th March 2021

The US Food and Drug Administration (FDA) has told two CBD companies they fell short of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals and ordered them to undertake proper testing ...

FTC-targeted company remains defiant, sees administrative fine as a victory

Written by CannIntelligence | 26th March 2021

The CEO of one company targeted by the US Federal Trade Commission (FTC) in the first ever group of fines handed down by the government agency to CBD companies considers the event to be a...

Mixed feelings as UK industry sees pros and cons in FSA switch on novel foods

Written by CannIntelligence | 25th March 2021

Industry reaction to the change in UK Food Standards Agency (FSA) novel food submission requirements is mixed, some welcoming it while others say it reveals failings of management and understanding ...

Canopy happy to put the US fate of its CBD sparkling water drink in the stars

Written by Lorraine Mullaney | 24th March 2021

Cannabis giant Canopy Growth has defended its decision to use a celebrity astrologer to promote the US launch of its CBD-infused sparkling water drink Quatreau ...

ValidCare reports to US FDA that trials find no evidence of CBD liver toxicity

Written by Freddie Dawson | 23rd March 2021

No evidence of liver toxicity from CBD has been found in the ValidCare study, the results of which have been given to the US Food and Drug Administration (FDA) for review ...

GenCanna acquires white label company Taylor Mammon in transatlantic merger

Written by Freddie Dawson | 22nd March 2021

UK white label CBD company Taylor Mammon has been acquired by US hemp firm GenCanna ...

PG/phytol research should come with a health warning – lab rats are not humans

Written by CannIntelligence | 19th March 2021

Any conclusion drawn from studies on rodents must be treated with caution if we want to know about effects on humans ...

With ingredient prices tumbling, why are CBD consumers still paying so much?

Written by CannIntelligence | 18th March 2021

A drop in the cost of bulk CBD has not yet been wholly reflected in falling CBD product prices – but are we about to witness a perfect storm for a race to the...

Not now, but soon – new industry bodies prepare for Brazil opening up to hemp

Written by CannIntelligence | 18th March 2021

Brazil still faces a serious attitude problem when it comes to advancing regulations for hemp and CBD, according to the leaders of two recently launched industry associations in the country ...

UK Food Standards Agency relaxes the rules slightly on novel food submissions

Written by Lorraine Mullaney | 15th March 2021

Companies now only to have submitted an application to the UK Food Standards Agency (FSA) in order for their edible CBD products to stay on the market after 1st April ...

US market to top $3bn in two years, but Swiss remain the biggest CBD users

Written by CannIntelligence | 15th March 2021

Swiss consumers are head-for-head the biggest purchasers of CBD products, according to CBD-Intel’s 2021 market size analysis. Meanwhile, we predict big growth in a number of other markets, and a shift in the most popular...

Pregnant mice study touches on FDA questions, but more research is needed

Written by CannIntelligence | 12th March 2021

The US Food and Drug Administration (FDA) has called for an exploration of the effects of CBD on certain vulnerable populations such as children and pregnant women as part of its consumer update ...

BAT moves further into cannabinoids with Organigram research deal

Written by Freddie Dawson | 11th March 2021

British American Tobacco (BAT) has continued its expansion into the cannabinoid space by signing a research collaboration agreement with Organigram, a licensed Canadian cannabis producer ...

Anxiety in Northern Ireland, UK's EU gateway, as novel food deadline looms

Written by CannIntelligence | 11th March 2021

As the UK’s deadline for novel food applications looms, many firms are upbeat about the prospects for CBD businesses in Northern Ireland, but almost all those CBD-Intel spoke to expressed frustration at a lack of...

Armenia looks to hemp legalisation as part of a route out of national crisis

Written by CannIntelligence | 10th March 2021

Crisis-hit Armenia intends to legalise and regulate the production of hemp as a part of a package of economic measures to alleviate issues arising from the military conflict with Azerbaijan over the Nagorno-Karabakh region ...

Wrigley's heir goes public with $1.9bn plan to 'transform US cannabis industry'

Written by Lorraine Mullaney | 9th March 2021

The heir to the Wrigley’s chewing gum fortune, Beau Wrigley, has entered into a deal he claims will accelerate the growth of his multi-state cannabis company, Parallel, and change the landscape of the US cannabis...

Hexo buys Zenabis 'for accelerated domestic and international growth'

Written by Lorraine Mullaney | 8th March 2021

Canadian cannabis brand Hexo has acquired medical and recreational cannabis producer Zenabis Global in a CAD 235m deal that will boost its cultivation capacity and secure a footprint in the European market ...

LATEST ALERTS

Written by Lorraine Mullaney | 11th May 2021

Written by CannIntelligence | 10th May 2021

Written by Lorraine Mullaney | 7th May 2021

Written by Lorraine Mullaney | 6th May 2021

Written by CannIntelligence | 3rd May 2021

Written by CannIntelligence | 30th April 2021

Written by CannIntelligence | 29th April 2021

Written by CannIntelligence | 28th April 2021

Written by Freddie Dawson | 23rd April 2021

Written by CannIntelligence | 21st April 2021

Written by Lorraine Mullaney | 21st April 2021

Written by Lorraine Mullaney | 20th April 2021

Written by CannIntelligence | 19th April 2021

Written by CannIntelligence | 19th April 2021

Written by CannIntelligence | 16th April 2021

Written by Anthony Traurig | 16th April 2021

Written by CannIntelligence | 15th April 2021

Written by Lorraine Mullaney | 15th April 2021

Written by CannIntelligence | 14th April 2021

Written by CannIntelligence | 14th April 2021

Written by CannIntelligence | 13th April 2021

Written by CannIntelligence | 13th April 2021

Written by CannIntelligence | 12th April 2021

Written by CannIntelligence | 9th April 2021

Written by CannIntelligence | 8th April 2021

Written by CannIntelligence | 7th April 2021

Written by CannIntelligence | 6th April 2021

Written by CannIntelligence | 6th April 2021

Written by Lorraine Mullaney | 2nd April 2021

Written by CannIntelligence | 1st April 2021

Written by CannIntelligence | 31st March 2021

Written by Freddie Dawson | 31st March 2021

Written by CannIntelligence | 30th March 2021

Written by Freddie Dawson | 29th March 2021

Written by CannIntelligence | 26th March 2021

Written by CannIntelligence | 25th March 2021

Written by Lorraine Mullaney | 24th March 2021

Written by Freddie Dawson | 23rd March 2021

Written by Freddie Dawson | 22nd March 2021

Written by CannIntelligence | 19th March 2021

Written by CannIntelligence | 18th March 2021

Written by CannIntelligence | 18th March 2021

Written by Lorraine Mullaney | 15th March 2021

Written by CannIntelligence | 15th March 2021

Written by CannIntelligence | 12th March 2021

Written by Freddie Dawson | 11th March 2021

Written by CannIntelligence | 11th March 2021

Written by CannIntelligence | 10th March 2021

Written by Lorraine Mullaney | 9th March 2021

Written by Lorraine Mullaney | 8th March 2021

Sign up to our newsletter

Start your FREE trial